Efficacy of Remote Patient Monitoring
The Impact of a Remote Patient Care Program on Healthcare Costs and Utilization Among Medicare Patients with Chronic Disease. Feldman, D. I., Reynolds, S., Babikian, S., Stein, B., Schlicher, J., Cunningham, E., Feldman, T., Curnow, R., Zheng, J., Budhiraja, P., Fudim, M. (2025) Mayo Clinic Proceedings: Innovations, Quality and Outcomes, Volume 10, Issue 1. https://doi.org/10.1016/j.mayocpiqo.2025.100679
- The Cadence Remote Patient Care (RPC) Program decreased total cost of care by $1,302 per patient per year (p<0.01).
- The Cadence RPC program reduced utilization demonstrating a 27% reduction in hospital admissions, equivalent to 64 fewer hospitalizations per 1,000 patients when compared to a propensity match control group.
Scaling remote patient care: The mechanics of a paradigm shift in chronic disease management. Feldman, D. I., Schlicher, J., Baars, K., Kooser, K., Silberman, S., & Cunningham, E. (2025). NEJM Catalyst, 6(11). https://doi.org/10.1056/cat.24.0521
Providence’s Remote Patient Care Program demonstrated a 43% relative increase in blood-pressure control, a 107% increase in HFrEF patients on all four GDMT pillars, and a 300% increase for HFpEF patients.
Patients showed high engagement with the program, consistently measuring vitals and participating in clinical encounters. Patient satisfaction, measured through post-encounter surveys was rated 4.9/5 and Net Promoter Score (NPS) of 40.
- Delivered a 70% relative increase in patients reaching guideline-directed BP goals at follow-up (p<0.001)
- Achieved an average 7/5 mmHg drop in BP (p<0.001)
- Heart-failure patients enrolled in Cadence’s program saw up to 3 times higher GDMT uptake.
- A 52% reduction in total cost of care was observed for Heart failure patients enrolled in Cadence driven largely by decreases in hospital and SNF spending.
The Effect of a Nationwide Remote Patient Intervention Diabetes Program on Blood Glucose Control. Feldman, D. I., Campbell, M., Feldman, T., Curnow, R., Fudim, M. (2024) Journal of the American College of Cardiology, Volume 83 (13_Supplement). https://doi.org/10.1016/S0735-1097(24)04439-5
- Cadence’s RPC program enabled 43% of patients to reach their blood glucose goal (BG <154 mg/dL) after 6 months in the program.